Metropolis Healthcare — 360° view

Metropolis Healthcare, a company in the Healthcare Service Provider industry, reported revenue of ₹497 crore and net profit of ₹75 crore for the September 2026 quarter.

Metropolis Healthcare (NSE: METROPOLIS) closed at ₹566.00 on 20 Nov 2026, up 15.5% over the past year. Its market capitalisation is ₹11,746 crore and it trades at 50.9 times earnings.

Share price
₹566.00 (20 Nov 2026)
Market cap
₹11,746 Cr (20 Nov 2026)
P/E
50.89 (20 Nov 2026)
Revenue
₹497 Cr (September 2026 quarter)
Net profit
₹75 Cr (September 2026 quarter)
ROCE
17.8% (FY26)
ROE
13.6% (FY26)
Book value
₹79.1 (FY26)
Dividend yield
0.35% (last 12 months to 20 Nov 2026)
52-week high / low
₹609.05 / ₹412.25 (20 Nov 2026)
1-year return
15.5% (to 20 Nov 2026)
Sector
Healthcare
Industry
Healthcare Service Provider
Symbol
NSE: METROPOLIS

Metropolis Healthcare Limited is one of the leading Indian diagnostics companies. The Company owns a chain of diagnostic centres across India, South Asia, Africa and the Middle East.

Descriptive research only, not investment advice. Evenstocks is not a SEBI-registered investment adviser.